XML 14 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 1,300,402 $ 1,133,649 $ 3,701,290 $ 3,263,201
Cost of revenue 668,325 555,020 1,884,906 1,584,686
Gross profit 632,077 578,629 1,816,384 1,678,515
Operating expenses:        
Research and development 262,311 261,511 760,101 764,753
Sales and marketing 220,627 215,560 653,464 647,888
General and administrative 108,191 106,452 301,800 333,309
Total operating expenses 591,129 583,523 1,715,365 1,745,950
Income (loss) from operations 40,948 (4,894) 101,019 (67,435)
Other (expenses) income, net:        
Share of losses from equity method investment (27,506) (25,279) (72,199) (78,794)
Other income, net 19,242 26,522 64,040 71,174
Total other (expenses) income, net (8,264) 1,243 (8,159) (7,620)
Income (loss) before benefit from (provision for) income taxes 32,684 (3,651) 92,860 (75,055)
Benefit from (provision for) income taxes 4,564 (6,075) (13,172) (21,878)
Net income (loss) attributable to common stockholders $ 37,248 $ (9,726) $ 79,688 $ (96,933)
Earnings Per Share [Abstract]        
Basic (in dollars per share) $ 0.24 $ (0.06) $ 0.52 $ (0.57)
Diluted (in dollars per share) $ 0.23 $ (0.06) $ 0.50 $ (0.57)
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders:        
Basic (in shares) 153,119,639 159,091,110 153,211,538 170,063,452
Diluted (in shares) 159,209,951 159,091,110 160,212,338 170,063,452